Computed Drug–Indication Atlas logo
MBRS Bio Terminal
Dashboard • [email protected] (upgrade request) Sign in required
Query MBRS Bio Functions
Interaction
Find biology-vs-expectation gaps and catalyst risk.
How should this user interact with the data?
Choose a mode. Switching later keeps the open tabs from the other mode intact.
Search assets, companies, indications, or type a BIO function…
Low
High
C
H
I
Asset / Indication
Headline
MBRS
Bio
Rank
Compass
Combo
Status
C
H
I
AJ1-11095 1171 → Post Polycythaemia Vera Myelofibrosis
Open · Historical graphs · Insight
UNFAVORABLE
0.42
0.50
0.50
3 / 6
0.24
1.00
C
H
I
AJ1-11095 438 → Polycythemia Vera
Open · Historical graphs · Insight
UNFAVORABLE
0.42
0.51
0.51
9 / 9
0.20
0.91
C
H
I
Fulvestrant → Breast Cancer
Open · Historical graphs · Insight
UNFAVORABLE
0.61
0.64
0.64
2 / 14
0.58
0.67
C
H
I
NVP-LDE225 → Idiopathic Myelofibrosis
Open · Historical graphs · Insight
UNFAVORABLE
0.53
0.56
0.56
5 / 15
0.49
0.71
Upgrade access

Full MBRS Bio Terminal access for biological risk, differentiation, mispricing, and landscape-shift analysis.

Submit a subscription request with the user logins you want approved. You can approve access manually after review.

Full access benefits
Expanded dataset size: broader asset-indication landscapes beyond guest/demo views.
Update frequency: refreshable biological risk surfaces as new runs, literature, trial, and competitor signals are processed.
Team share: shared decision context across VC, BD, Hedge, and Family Office views.
Data processing: support for submitted assets, indications, competitor sets, and personalized risk questions.
Personalized risk submissions: request custom biological risk outputs for assets, indications, combinations, and landscape scenarios.
Monthly plan selection
Request approval
Sign in first, then submit this request so it can be tied to your account. Go to login
Selected: Individual · 1 user. Requests remain pending until an admin approves the listed login/account in Supabase.